AU Stock MarketDetailed Quotes

NUZ Neurizon Therapeutics Ltd

Watchlist
  • 0.120
  • 0.0000.00%
20min DelayTrading May 1 10:07 AET
59.08MMarket Cap-5.71P/E (Static)

About Neurizon Therapeutics Ltd Company

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Company Profile

SymbolNUZ
Company NameNeurizon Therapeutics Ltd
Founded2000
MarketASX
Employees52
Fiscal Year Ends06-30
Address96-100 Albert Road Level 4
CityMelbourne
CountryAustralia
Zip Code3205
Phone+61 396927222
Share RegistryAUTOMIC REGISTRY SERVICES Suite 5, Level 12, 530 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000 1300 288 664

Company Executives

  • Name
  • Position
  • Salary
  • Michael Thurn
  • Chief Executive Officer,Managing Director
  • --
  • Sergio Duchini
  • Non-Executive Chairman,Non-Executive Director
  • --
  • Marcus Hughes
  • Non-Executive Director
  • --
  • Kathryn(Katie) MacFarlane
  • Non-Executive Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More